These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 11963637

  • 1. [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data].
    Paoletti V, Di Veroli C, Pugliese M, Cammarella I, Cavina G, Turchetti P, Mammarella A.
    Clin Ter; 2002; 153(1):61-4. PubMed ID: 11963637
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. AT1-receptor blockers.
    Petkun W.
    Eur Heart J; 2000 Feb; 21(4):335-7. PubMed ID: 10653684
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiology patient page. Angiotensin receptor blockers.
    Terra SG.
    Circulation; 2003 Jun 24; 107(24):e215-6. PubMed ID: 12821593
    [No Abstract] [Full Text] [Related]

  • 8. The relationships between dose and antihypertensive effect of four AT1-receptor blockers. Differences in potency and efficacy.
    Elmfeldt D, Olofsson B, Meredith P.
    Blood Press; 2002 Jun 24; 11(5):293-301. PubMed ID: 12458652
    [Abstract] [Full Text] [Related]

  • 9. [Tendency and prospect of the development of new ARBs].
    Kim S.
    Nihon Rinsho; 2002 Oct 24; 60(10):1881-6. PubMed ID: 12397678
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II receptor antagonists in the treatment of hypertension.
    Kaplan NM.
    Am Fam Physician; 1999 Sep 15; 60(4):1185-90. PubMed ID: 10507747
    [Abstract] [Full Text] [Related]

  • 11. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA.
    J Hypertens Suppl; 1997 Dec 15; 15(6):S31-6. PubMed ID: 9493125
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
    Coats AJ.
    Int J Cardiol; 2001 Jul 15; 79(2-3):99-102. PubMed ID: 11461726
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of angiotensin II antagonists in hypertension.
    Spence JD.
    Can J Cardiol; 1999 Nov 15; 15 Suppl F():33F-5F. PubMed ID: 10579750
    [Abstract] [Full Text] [Related]

  • 14. [Dosage equivalents of AT1-receptor antagonists available in Germany].
    Dominiak P, Häuser W.
    Dtsch Med Wochenschr; 2003 Oct 31; 128(44):2315-8. PubMed ID: 14593575
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Angiotensin I receptor antagonist losartan. Part II. Effects in arterial hypertension and diabetic nephropathy].
    Sidorenko BA, Preobrazhenskiĭ DV, Stetsenko TM, Tarykina EV, Tsurko VV.
    Kardiologiia; 2003 Oct 31; 43(2):88-95. PubMed ID: 12891278
    [Abstract] [Full Text] [Related]

  • 17. [spACE, the last frontier? Renin inhibition in hypertension].
    Villa L.
    G Ital Nefrol; 2008 Oct 31; 25(3):274. PubMed ID: 18473295
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Newly emerging pharmacologic differences in angiotensin II receptor blockers.
    Oparil S.
    Am J Hypertens; 2000 Jan 31; 13(1 Pt 2):18S-24S. PubMed ID: 10678284
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T, Hashimoto J, Ohkubo T, Kikuya M, Metoki H, Asayama K, Totsune K, Imai Y.
    Clin Exp Hypertens; 2005 Aug 31; 27(6):477-89. PubMed ID: 16081340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.